Navigation Links
Fiserv Reports Strong Earnings for Third Quarter of 2005

Brookfield, Wis. Fiserv, Inc. announced strong earnings for the third quarter of 2005. Net income per share-diluted from continuing operations for the third quarter of 2005 was $0.58 per share, compared to $0.53 per share for the third quarter of 2004. Processing and services revenues were $925.3 million, an increase of 10% over the third quarter of 200......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 10/21/05


Page: 1

Related biology technology :

1. Fiserv reports $113.5 million in Q1 profit
2. Former Fiserv exec to enter Business Hall of Fame
3. Fiserv acquires crime management software firm
4. Fiserv posts 30 percent quarterly loss
5. Fiserv reports stronger earnings and revenues
6. Fiservs Banklink chosen by Union Bank of California
7. Fiserv makes over $1 billion, but profits decline
8. Fiserv to partner with PassMark Security
9. Fiserv crosses Fortune 500 threshold
10. Fiserv acquires insurance, training product lines
11. Fiserv unit adds healthcare payment processor
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... Research and Markets has announced the addition of ... offering. ... The Global Market for Bioproducts Should Reach $714.6 Billion ... of 8.9%, This research report quantifies the ... product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and herbal/botanicals), biocomposite ...
(Date:3/23/2017)... March 23, 2017  SeraCare Life Sciences, ... in vitro diagnostics manufacturers and clinical laboratories, ... first multiplexed Inherited Cancer reference material ... by next-generation sequencing (NGS). The Seraseq™ Inherited Cancer ... input from industry experts to validate the ...
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
Breaking Biology Technology:
(Date:3/2/2017)... March 2, 2017 Australian stem cell and ... CYP), has signed an agreement with the Monash Lung ... Biomedicine Discovery Institute and Department of Pharmacology at Monash ... further preclinical study to support the use of Cymerus™ ... Asthma is a chronic, long term ...
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , ... software globally, announces significant enhancements to new and core ... 2016. New products include mobile and desktop Acuant FRM ... TM - a real time manual review of ... idScan® technology provides the fastest and most accurate capture ...
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ein ... wird seine erstklassige biometrische Lösung zur Iris-Erkennung ... mit X16 LTE auf dem Mobile World ... am Qualcomm-Stand in Halle 3, Stand 3E10, ... die Sicherheitsplattform Qualcomm Haven™ – eine Kombination ...
Breaking Biology News(10 mins):